NCT00604344View on ClinicalTrials.gov

Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

401

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY